[{"type": "title", "data": "CARD GP llb / llla Inhibitor (eptifibatide) (Module)"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "Indications for GP IIb/IIIa Inhibitors:   \n- Very high risk patients awaiting PCI who have ongoing / recurrent ischemia despite dual antiplatelet therapy and anticoagulant (Risk stratification using the Grace Risk Score). \nDiscuss with interventional or local cardiologist prior to ordering", "value": ""}, {"type": "note", "data": "CONTRAINDICATIONS to GP IIb / IIIa Inhibitors:   \n- History of bleeding diathesis or active bleeding within the previous 30 days  \n - Major surgery or severe trauma within the preceding month   \n- Severe uncontrolled hypertension (SBP greater than 200 mmHg OR DBP greater than 110 mmHg)   \n- History of stroke within 30 days or any history of hemorrhagic stroke   - History of intracranial hemorrhage, intracranial neoplasm, AV malformation, or aneurysm   \n- Clinically significant liver disease   - Platelet count less than 100 x 10^9/L   - Aortic dissection, acute pericarditis, or vasculitis   - Current use of warfarin (use caution)", "value": ""}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Do NOT use eptifibatide if eGFR is less than 20 mL/min", "value": ""}, {"type": "note", "data": "For PCI, infuse for 18 to 24 hours, for unstable angina / NSTEMI, infuse for up to 72 hours", "value": ""}, {"type": "order", "data": "eptifibatide", "value": ""}, {"type": "sentence", "data": "180 mcg/kg, IV, once, drug form: inj"}, {"type": "sentence", "data": "20 mg, IV, once, drug form: inj"}, {"type": "note", "data": "Maintenance dose: for eGFR greater than 50 mL/min", "value": ""}, {"type": "order", "data": "eptifibatide continuous infusion (0.75 mg/mL) standard", "value": ""}, {"type": "sentence", "data": "2 mcg/kg/min, IV, order duration: 18 hour, drug form: inj"}, {"type": "sentence", "data": "75 mg, 2 mcg/kg/min"}, {"type": "note", "data": "Maintenance dose: for eGFR between 20 to 50 mL/min", "value": ""}, {"type": "order", "data": "eptifibatide continuous infusion (0.75 mg/mL) standard", "value": ""}, {"type": "sentence", "data": "1 mcg/kg/min, IV, order duration: 18 hour, drug form: inj"}, {"type": "sentence", "data": "75 mg, 1 mcg/kg/min"}, {"type": "category", "data": "Laboratory"}, {"type": "order", "data": "CBC and Differential", "value": ""}, {"type": "sentence", "data": "Blood, AM Draw, Collection: T+1;0330, qdaily"}, {"type": "order", "data": "Notify Treating Provider Laboratory Results", "value": ""}, {"type": "sentence", "data": "If platelet count less than 100 x 10^9/L"}, {"type": "order", "data": "Conditional Order - Nurse to Place Lab Order - One Time", "value": ""}, {"type": "sentence", "data": "If/when eptifibatide infusion initiated, then order CBC and Differential, routine, once, 4 hours post initiation"}, {"type": "order", "data": "Conditional Order - Nurse to Place Lab Order - One Time", "value": ""}, {"type": "sentence", "data": "If/when eptifibatide infusion terminate, then order CBC and Differential, routine, once, 24 hours after termination"}]
